Back to Companies who have applied for FDA Drug Approval

FDA Drug Approval Applications Sponsored by ASTRAZENECA PHARMS

Application NumberDrugs/ProductsApplication TypeMost Recent Label Available FlagCurrent Patent FlagAction TypeChemical TypeTher PotentialOrphan Code
019810 New Drug Application Approval New molecular entity (NME) (P) Priority review drug
019962 New Drug Application Approval New ester, new salt, or other noncovalent derivative (S) Standard review drug
020639 New Drug Application Approval New molecular entity (NME) (S) Standard review drug
020746 New Drug Application Approval New formulation (S) Standard review drug
020929 New Drug Application Approval New formulation (P) Priority review drug
021153 New Drug Application Approval New ester, new salt, or other noncovalent derivative
021229 New Drug Application Approval New ester, new salt, or other noncovalent derivative; New formulation (S) Standard review drug
021689 New Drug Application Approval New formulation (S) Standard review drug
021957 New Drug Application Approval New formulation (S) Standard review drug
022056 New Drug Application Approval New formulation (S) Standard review drug
022101 New Drug Application Approval New formulation (S) Standard review drug
022522 New Drug Application Approval New molecular entity (NME) (S) Standard review drug
202450 New Drug Application Approval New molecular entity (NME) (S) Standard review drug
204760 New Drug Application Approval New molecular entity (NME) (P) Priority review drug
205060 New Drug Application Approval New manufacturer (S) Standard review drug
206162 New Drug Application Approval New molecular entity (NME) (P) Priority review drug
206995 New Drug Application Approval New manufacturer (S) Standard review drug
208065 New Drug Application Approval New molecular entity (NME) (P) Priority review drug (V) Orphan drug

Back to Companies who have applied for FDA Drug Approval